concept

METABOLIC REPROGRAMMING

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about METABOLIC REPROGRAMMING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

68Connections

25Hypotheses

4Analyses

28Outgoing

40Incoming

3Experiments

12Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	METABOLIC REPROGRAMMING
Key Genes/Proteins	APP, LRP1, MTOR, NLRP3, PINK1
Related Diseases	ATP, INFLAMMATION, MITOPHAGY, OXIDATIVE STRESS
Related Pathways	PI3K/AKT PATHWAY

Pathway Diagram

graph TD
    METABOLIC_REPROGRAMMING["METABOLIC REPROGRAMMING"]
    METABOLIC_REPROGRAMMING -->|"mediates"| Cardiac_Aging["Cardiac Aging"]
    METABOLIC_REPROGRAMMING -->|"causes"| Gemcitabine_Resistance["Gemcitabine Resistance"]
    METABOLIC_REPROGRAMMING -->|"modulates"| Cardiac_Function["Cardiac Function"]
    METABOLIC_REPROGRAMMING -->|"contributes to"| Antibacterial_Defence["Antibacterial Defence"]
    METABOLIC_REPROGRAMMING -->|"contributes to"| Endothelial_Cell_Dysfunction["Endothelial Cell Dysfunction"]
    METABOLIC_REPROGRAMMING -->|"contributes to"| Sepsis_Associated_Acute_Kidney["Sepsis-Associated Acute Kidney Injury"]
    STAT3["STAT3"] -->|"regulates"| METABOLIC_REPROGRAMMING
    INFLAMMASOME["INFLAMMASOME"] -->|"causes"| METABOLIC_REPROGRAMMING
    HIF1A["HIF1A"] -->|"mediates"| METABOLIC_REPROGRAMMING
    PI3K_AKT_HIF1A["PI3K/AKT/HIF1A"] -->|"mediates"| METABOLIC_REPROGRAMMING
    TREM2["TREM2"] -->|"regulates"| METABOLIC_REPROGRAMMING
    PI3K_Akt_HIF1__Pathway["PI3K/Akt/HIF1alpha Pathway"] -->|"mediates"| METABOLIC_REPROGRAMMING
    ubiquitin_proteasome_system["ubiquitin-proteasome system"] -->|"modulates"| METABOLIC_REPROGRAMMING

Outgoing (28)

Target	Relation	Type	Str
Mitochondrial Biogenesis	promotes	process	0.95
Stress Resilience	promotes	phenotype	0.95
Atp Production	upregulates	phenotype	0.95
Cardiac Aging	mediates	process	0.92
Cardiac Aging	modulates	process	0.90
Cellular Senescence	associated_with	process	0.90
Gemcitabine Resistance	causes	phenotype	0.90
Cancer Progression	contributes_to	phenotype	0.88
Cardiovascular Disease	treats	disease	0.85
Cardiac Function	regulates	phenotype	0.85
Pentose Phosphate Pathway	associated_with	pathway	0.85
Sepsis-Associated Acute Kidney Injury	contributes_to	disease	0.85
Antibacterial Defence	contributes_to	process	0.85
Pulmonary Arterial Endothelial Cell Dysfunction	contributes_to	process	0.85
Glycolysis	associated_with	pathway	0.85
Cardiac Function	modulates	phenotype	0.85
Endothelial Cell Dysfunction	contributes_to	phenotype	0.85
Antibacterial Defense Responses	mediates	process	0.85
Myocardial Fibrosis	involved_in	phenotype	0.82
Myocardial Hypertrophy	involved_in	phenotype	0.82
cancer cell survival	contributes_to	unknown	0.75
protein function	normalizes	process	0.70
cellular senescence	modulates	process	0.70
MICROGLIA	activates	cell_type	0.65
MICROGLIA	implicated_in	cell_type	0.55
neuronal senescence	reverses	mechanism	0.50
PI3K/AKT PATHWAY	associated_with	pathway	0.45
FINGOLIMOD	associated_with	drug	0.45

Incoming (40)

Source	Relation	Type	Str
HIF1A	associated_with	gene	0.95
STAT3	regulates	protein	0.95
INFLAMMASOME	causes	protein	0.90
HIF1A	mediates	protein	0.90
PI3K/AKT/HIF1A	mediates	pathway	0.90
Ubiquitin-Proteasome System	involved_in	pathway	0.90
CRISPR	promotes	mechanism	0.90
Microglia	associated_with	cell_type	0.90
TREM2	regulates	protein	0.88
Hypoxia	associated_with	process	0.85
HIF-1Α	associated_with	protein	0.85
PI3K/Akt/HIF1α Pathway	mediates	pathway	0.85
Ubiquitin-Proteasome System	regulates	pathway	0.85
FDX1	regulates	protein	0.85
PI3K/AKT/mTOR Signaling	mediates	pathway	0.85
ubiquitin-proteasome system	modulates	pathway	0.85
IDH2	associated_with	gene	0.80
MTORC2	mediates	protein	0.80
P53	regulates	gene	0.80
HIF1α	mediates	protein	0.80
AMPK-HIF-1α signaling	mediates	unknown	0.78
Epigenetic Modifications	associated_with	mechanism	0.75
GFAP-reactive astrocytes	undergoes	cell_type	0.70
SIRT1-PGC-1alpha-NAMPT axis	regulates	pathway	0.70
lactylation	regulates	process	0.70
SIRT1	modulates	protein	0.70
PINK1	inhibits	gene	0.65
ATP	causes	phenotype	0.65
OXIDATIVE STRESS	activates	phenotype	0.65
MACROPHAGE	regulates	cell_type	0.65
MTOR	regulates	gene	0.65
MICROGLIA	regulates	cell_type	0.65
INFLAMMATION	regulates	phenotype	0.65
NLRP3	regulates	gene	0.65
APP	causes	gene	0.65
APP	inhibits	gene	0.65
LRP1	regulates	gene	0.65
MACROPHAGES	regulates	cell_type	0.65
MITOPHAGY	implicated_in	phenotype	0.55
30930170	may have relevance to	paper	0.30

Targeting Hypotheses (25)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TREM2-mTOR Co-Agonism for Metabolic Reprogramming	0.803	neurodegeneration	TREM2 agonism vs antagonism in DAM micro
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming	0.748	neurodegeneration	Gene expression changes in aging mouse b
Metabolic Reprogramming to Reverse Senescence	0.720	-	Senescent cell clearance as neurodegener
Metabolic Reprogramming via Microglial Glycolysis Inhibition	0.672	neurodegeneration	Synaptic pruning by microglia in early A
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem	0.646	neurodegeneration	Selective vulnerability of entorhinal co

Cell-Type Specific Metabolic Reprogramming	0.643	neurodegeneration	Cell type vulnerability in Alzheimers Di
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P	0.643	neurodegeneration	Senolytic therapy for age-related neurod
Astrocyte Metabolic Reprogramming via APOE4 Correction	0.636	neurodegeneration	Cell type vulnerability in Alzheimer's D
Disease-Associated Microglia Metabolic Reprogramming	0.631	neurodegeneration	Cell type vulnerability in Alzheimers Di
NRF2-Mediated Metabolic Reprogramming: HBOT as Direct NAMPT/	0.602	neurodegeneration	View
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci	0.599	neurodegeneration	CRISPR-based therapeutic approaches for
APOE4 drives astrocyte metabolic reprogramming toward glycol	0.580	neuroscience	APOE4-driven lipid metabolism dysregulat
Digital Twin-Guided Metabolic Reprogramming	0.550	neurodegeneration	Digital biomarkers and AI-driven early d
TREM2-Mediated Microglial Metabolic Reprogramming Accelerate	0.494	neuroscience	Circuit-level neural dynamics in neurode
Oligodendrocyte Progenitor Cell Metabolic Reprogramming	0.486	neurodegeneration	Which cell types show the most significa
Multi-Target Microglial Metabolic Reprogramming	0.480	neurodegeneration	TREM2 Therapeutic Strategy Post-INVOKE-2
Circadian Metabolic Reprogramming Therapy	0.455	chronobiology	Can circadian interventions reverse micr
SPI1-Mediated Metabolic Reprogramming in Neuroinflammation	0.455	neuroinflammation	How does SPI1 transcriptionally regulate
Metabolic Reprogramming Toward GAPDH Inhibition	0.450	neurodegeneration	How does controlled lysosomal membrane p
TBK1 Deficiency Disrupts Microglial Metabolic Reprogramming,	0.406	ALS	What are the mechanisms by which microgl
NAD+-SIRT1-H3K9me3 restoration enables true senescence rever	0.380	Alzheimer's disease	Can metabolic interventions truly revers
CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metab	0.380	developmental neurobiology	Do perinatal immune challenges create pe
Microglial Phenotypic Polarization via CSF1R-Mediated Metabo	0.380	developmental neurobiology	Do perinatal immune challenges create pe
CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metab	0.351	developmental neurobiology	Do perinatal immune challenges create pe
Mitochondrial Pyruvate Carrier Inhibition to Force Metabolic	0.347	metabolomics	Metabolomic signatures of neurodegenerat

Mentioning Analyses (4)

Scientific analyses that reference this entity

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

neurodegeneration | 2026-04-10 | 0 hypotheses

What molecular mechanisms drive tissue-specific phenotypes in Mendelian neurolog

neurodegeneration | 2026-04-08 | 1 hypotheses Top: 0.280

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.769

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-02 | 0 hypotheses

Experiments (3)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Clinical outcome analysis based on IDH mutation status	clinical	gliomas	0.850	0.00	human patients	proposed	N/A
Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an	falsification	Neurodegeneration	0.400	0.50	cell_line	completed	$100,000
Proposed experiment from debate on Microglia activate astrocytes via I	falsification	Neuroinflammation	0.400	0.50	cell_line	completed	$80,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Saturation mutagenesis of twenty disease-associated regulatory elements at singl [PMID:31395865]	["Kircher M", "Xiong C", "Martin B", "Sc	Nature Communications	2019	267
Bergenin attenuates traumatic brain injury via inhibition of microglial PFKFB3-d [PMID:41520557]	Sun B, Zhang A, Feng S, Jamali AW, Jia Z	Int Immunopharmacol	2026	1
HK1 and HK2 Beyond Glycolysis: Mitochondrial Interactions and Dual Roles in Meta [PMID:41387352]	Pesce NA, Seminara G, Giarrusso G, Tomas	Adv Biol (Weinh)	2026	1
Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative [PMID:39987285]	Fang M, Zhou Y, He K, Lu Y, Tao F, Huang	Mol Neurobiol	2025	1
Deficiency of Microglial Hv1 Protects Against Lipopolysaccharide-Induced Neuroin [PMID:40911376]	Sun L, Wang X, Guan S, Zhang P, Chen D,	FASEB J	2025	1
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. [PMID:38904014]	Fontana F, Giannitti G, Marchesi S, Limo	Int J Biol Sci	2024	1
AST-120 alleviates renal ischemia-reperfusion injury by inhibiting HK2-mediated [PMID:39217289]	Zhou J, Zhang J, Xu F, Gao H, Wang L, Zh	Mol Med	2024	1
Hexokinase 2-mediated gene expression via histone lactylation is required for he [PMID:37463576]	Rho H, Terry AR, Chronis C, Hay N	Cell Metab	2023	1
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresista [PMID:36637036]	Shigeta K, Hasegawa M, Hishiki T, Naito	EMBO J	2023	1
NAD(+) metabolism, stemness, the immune response, and cancer. [PMID:33384409]	Navas LE, Carnero A	Signal Transduct Target Ther	2021	1
Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydr [PMID:31131326]	Tommasini-Ghelfi S, Murnan K, Kouri FM,	Sci Adv	2019	1
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcino [PMID:28622513]	Cancer Genome Atlas Research Network. El	Cell	2017	1
Diagnostic, prognostic and predictive relevance of molecular markers in gliomas. [PMID:25944653]	Brandner S, von Deimling A	Neuropathol Appl Neurobiol	2015	1
IDH1 and IDH2 mutations in gliomas. [PMID:19228619]	Yan H, Parsons DW, Jin G, McLendon R, Ra	N Engl J Med	2009	1
Modulating LRP1 Pathways in Alzheimer's Disease: Mechanistic Insights and Emergi [PMID:41772271]	Mushtaq T, Hameed H, Khan MA, Tariq U, H	Molecular neurobiology	2026	0
Crosstalk Between [PMID:41899603]	["Ren Y", "Tang D", "Ding X", "He M"]	Cancers	2026	0
Resibufogenin protects against atherosclerosis in ApoE(-/-) mice through blockin [PMID:40258472]	Xiaoyang C, Yijun C, Chenguang Z, Wanyin	J Adv Res	2026	0
High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence Fro [PMID:41406402]	Du Y, Borné Y, Samuelsson J, Glans I, Hu	Neurology	2026	0
Macrophage-Specific E3 Ubiquitin Ligase TRIM31 Reduces Atherosclerotic Plaque Fo [PMID:41410044]	Zhang J, Yu L, Yang W, Cao L, Wang X et	Circulation	2026	0
The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and [PMID:41527736]	Abedin MJ, Kastanenka KV	J Alzheimers Dis	2026	0

Debates (12)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

closed · Rounds: 0 · Score: 0.66 · 2026-04-21

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

closed · Rounds: 0 · Score: 0.64 · 2026-04-21

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

closed · Rounds: 4 · Score: 0.75 · 2026-04-16

The abstract identifies tissue-specific networks that may underlie Mendelian dis

closed · Rounds: 6 · Score: 0.95 · 2026-04-10

Related Research

Hypotheses and analyses mentioning METABOLIC REPROGRAMMING in their description or question text

Cell-Type Specific Metabolic Reprogramming

Score: 0.643 · neurodegeneration · 2026-04-13

## Mechanistic Overview Cell-Type Specific Metabolic Reprogramming starts from the claim that modulating PPARA within th

SASP-Driven Microglial Metabolic Reprogramming in Synaptic Phagocytosis

Score: 0.643 · neurodegeneration · 2026-04-07

## Mechanistic Overview SASP-Driven Microglial Metabolic Reprogramming in Synaptic Phagocytosis starts from the claim th

Astrocyte Metabolic Reprogramming via APOE4 Correction

Score: 0.636 · neurodegeneration · 2026-04-04

## Mechanistic Overview Astrocyte Metabolic Reprogramming via APOE4 Correction starts from the claim that modulating APO

Disease-Associated Microglia Metabolic Reprogramming

Score: 0.631 · neurodegeneration · 2026-04-12

## Mechanistic Overview Disease-Associated Microglia Metabolic Reprogramming starts from the claim that modulating TREM2

NRF2-Mediated Metabolic Reprogramming: HBOT as Direct NAMPT/SIRT1 Activator for

Score: 0.602 · neurodegeneration · 2026-04-17

## Mechanistic Overview NRF2-Mediated Metabolic Reprogramming: HBOT as Direct NAMPT/SIRT1 Activator for Reverse Senescen

Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Circuits

Score: 0.599 · neurodegeneration · 2026-04-02

## Mechanistic Overview Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Circuits starts from the claim that mo

APOE4 drives astrocyte metabolic reprogramming toward glycolysis via PGC-1α supp

Score: 0.580 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** The APOE4-driven metabolic reprogramming of astrocytes represents a complex casca

Digital Twin-Guided Metabolic Reprogramming

Score: 0.550 · neurodegeneration · 2026-04-02

## Mechanistic Overview Digital Twin-Guided Metabolic Reprogramming starts from the claim that modulating PPARGC1A/PRKAA

TREM2-Mediated Microglial Metabolic Reprogramming Accelerates Tau Pathological S

Score: 0.494 · neuroscience · 2026-04-21

## Mechanistic Overview TREM2-Mediated Microglial Metabolic Reprogramming Accelerates Tau Pathological Spread starts fro

Oligodendrocyte Progenitor Cell Metabolic Reprogramming

Score: 0.486 · neurodegeneration · 2026-04-04

## Molecular Mechanism and Rationale Oligodendrocyte progenitor cells (OPCs) undergo a critical metabolic transformatio

Multi-Target Microglial Metabolic Reprogramming

Score: 0.480 · neurodegeneration · 2026-04-27

Combinatorial targeting of TREM2, APOE, and CLU network with metabolic reprogramming toward anti-inflammatory microglial

Circadian Metabolic Reprogramming Therapy

Score: 0.455 · chronobiology · 2026-04-27

Timed delivery of NAD+ precursors and AMPK activators to reset microglial circadian metabolism from glycolytic pro-infla

SPI1-Mediated Metabolic Reprogramming in Neuroinflammation

Score: 0.455 · neuroinflammation · 2026-04-27

SPI1 transcriptionally coordinates both inflammatory gene expression and metabolic enzymes in activated microglia, shift

Metabolic Reprogramming Toward GAPDH Inhibition

Score: 0.450 · neurodegeneration · 2026-04-21

## Mechanistic Overview Metabolic Reprogramming Toward GAPDH Inhibition starts from the claim that modulating GAPDH, HK2

TBK1 Deficiency Disrupts Microglial Metabolic Reprogramming, Promoting Glycolyti

Score: 0.406 · ALS · 2026-04-26

TBK1 loss-of-function mutations in ALS disrupt microglial metabolic homeostasis by impairing mTOR-dependent metabolic ch